Location History:
- Tokyo, JP (1982 - 1984)
- Shizuoka, JP (1989 - 1991)
Company Filing History:
Years Active: 1982-1991
Title: Yukifumi Noda: Innovator in Pharmaceutical Chemistry
Introduction
Yukifumi Noda is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at improving psychoneural functions. With a total of 4 patents to his name, Noda's work is recognized for its potential impact on treating cognitive disorders.
Latest Patents
Noda's latest patents include innovative compounds such as 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline - 4-aminopyridine derivatives. These compounds are represented by a complex general formula that allows for various substitutions, making them versatile in their applications. They are particularly useful as active ingredients in pharmaceutical compositions aimed at treating Alzheimer-type dementia and enhancing mnemonic and learning performance. Additionally, he has developed a therapeutic agent for disorders associated with cerebral ischemia, which comprises N-(2-hydroxyethyl) nicotinamide nitrate as an active ingredient.
Career Highlights
Yukifumi Noda is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative research and development in the pharmaceutical sector. Noda's contributions have been instrumental in advancing therapeutic options for cognitive disorders.
Collaborations
Throughout his career, Noda has collaborated with notable colleagues, including Yasushi Murakami and Tomohiro Neichi. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.
Conclusion
Yukifumi Noda's innovative work in pharmaceutical chemistry highlights his commitment to improving cognitive health through advanced therapeutic solutions. His contributions continue to pave the way for future research and development in the treatment of neurodegenerative disorders.